Previous Close | 96.62 |
Open | 96.70 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's Range | 95.18 - 96.80 |
52 Week Range | 89.52 - 113.28 |
Volume | |
Avg. Volume | 4,277,473 |
Market Cap | 249.686B |
Beta (5Y Monthly) | 0.29 |
PE Ratio (TTM) | 22.53 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 3.00 (3.10%) |
Ex-Dividend Date | Apr 22, 2024 |
1y Target Est | N/A |
Weight loss drugs are rising in popularity, and food companies are cooking up new ways to win over those consumers.
The company says its Vital Pursuit line, priced under $5, is high in protein and vitamins, addressing nutrient deficiencies that Ozempic and Wegovy users may have.
Nestlé is launching a new range of protein-enriched pastas and pizzas for people taking weight-loss drugs, amid fears treatments like Wegovy will hammer sales.